Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Solvay fourth quarter and full year 2024 results

In This Article:

Solvay S.A.
Solvay S.A.

Press release


Regulated information

Solid EBITDA and free cash flow supported by cost savings acceleration

Brussels, March 6, 2025, 7.00am CET

Highlights

  • “Essential for Generations”: Solvay’s ambition is to be a leader in Essential Chemistry. Despite challenging market conditions in 2024, we proved the resilience of our business and our strong execution, delivering solid results. This allows us to confirm our 2028 EBITDA mid-single digit annual growth target.

  • Launch of the “For Generations” roadmap, defining the foundations of Sustainability at Solvay.

  • Underlying net sales in Q4 2024 were slightly up (+0.5% organically) compared to Q4 2023 despite lower pricing, with continued year-on-year growth in volumes for certain businesses such as Bicarbonate and Peroxides. Full year 2024 underlying net sales amounted to €4,686 million, down -4.0% organically versus 2023, with a positive impact from volumes for the fourth consecutive quarter, while prices were down year on year.

  • Underlying EBITDA in Q4 2024 increased year-on-year to €256 million (+2.0% organically), with 22.6% underlying EBITDA margin. Full year 2024 underlying EBITDA reached €1,052 million, down -8.2% organically, as positive volume and cost savings partially offset lower Net pricing. Underlying EBITDA margin was at 22.5% for the year.

  • Structural cost savings initiatives delivered €110 million in 2024, well above the target of €80 million thanks to the acceleration of savings initiatives at manufacturing sites and in corporate functions.

  • Underlying net profit from continuing operations was €445 million in 2024 vs. €588 million in 2023.

  • Free Cash Flow1 amounted to €361 million in 2024, underpinned by the solid EBITDA performance and the working capital discipline, while Capex accelerated in Q4 2024, as planned, to reach €355 million for the full year.

  • Underlying Net Debt remained stable at €1.5 billion, implying a leverage ratio of 1.5x.

  • Total proposed gross dividend of €2.43 per share, subject to shareholders’ approval during the next Ordinary General Meeting of May 13, 2025.

  • 2025 Outlook: Solvay expects the underlying EBITDA to be between €1.0 billion and €1.1 billion, and the Free Cash Flow1 to be around €300 million.


Fourth quarter

Full year

Underlying
(in € million)

2024

2023

% yoy

% organic

2024

2023

% yoy

% organic

Net sales

1,134

1,131

+0.3%

+0.5%

4,686

4,880

-4.0%

-4.0%

EBITDA

256

238

+7.4%

+2.0%

1,052

1,246

-15.6%

-8.2%

EBITDA margin

22.6%

21.1%

+1.5pp

-

22.5%

25.5%

-3.1pp

-

FCF 1

41

8

n.m.

-

361

561

-35.7%

-

ROCE





17.6%

20.4%

-2.8pp

-

Note: 2023 figures were restated to reflect the changes mentioned in the introduction to Financial performance.